Safety, ethics, dosage, vape pens, and the ibogaine combo—what 5‑MeO‑DMT actually demands, and how DMV readers should navigate it without hype.

DoubleBlind Mag spotlights rising 'pill shaming' in psychedelic spaces. Here’s what it means for people on SSRIs, the early research, and how DMV readers can stay safe.

MKUltra and modern psyops shape how patients judge claims. Here’s how DMV readers can vet medical marijuana delivery, dosing, and safety without falling for propaganda.

From Bicycle Day to modern art prints, here’s how LSD blotter design latched onto space themes—and why the revival matters for DC, Maryland, and Virginia culture.

The Family Acid archivist reflects on a life reshaped by LSD, Vietnam, reggae, and art—plus what this cultural history means for Virginia and the wider DMV today.

A Bay Area field party puts colossal hash‑hole “donut” joints center stage. Here’s how the ritual works, why it resonates, and what the DMV can take from it.

New research suggests festivals and ceremonial settings may nurture similar trauma relief through community and shared meaning—raising practical lessons for DMV readers.

Canada still leads cannabis exports, but South African producers say they can compete on quality and standards—not just price. Here’s how a shifting supply landscape could ripple through compliance, delivery, and consumer choice.

A University of Georgia analysis of 20M+ responses finds a 7% drop in health-related absences where medical cannabis is accessible, with strongest effects in physical jobs.

What cannabigerol (CBG) is, why scientists call it cannabis’s precursor cannabinoid, what preclinical research suggests, and how DMV patients should approach it today.

A Dec. 11 federal ban on intoxicating hemp products could hit retailers, delivery menus, and couriers nationwide. Here’s what DMV consumers and operators should prepare for.

A Republican gubernatorial candidate in Michigan is courting the cannabis industry by pledging to scrap a new 24% wholesale tax, while the Democratic opponent has not taken a position.

Headset Inc. will make staged payments through 2030 to settle allegations it improperly received a federal PPP loan because of its cannabis industry ties.

Ancient Sulawesi skeletons show extreme dental wear and arecoline residue—evidence, per High Times, that people used psychoactive areca nut long before recorded history.

Psychedelic Alpha spotlights Kimon de Greef’s look at 5‑MeO‑DMT’s ascent from Sonora to pharmaceutical interest. Here’s what DMV readers should watch and why it matters.

In a 7–0 decision, Nebraska’s high court left intact two 2024 initiatives approving medical cannabis and program rules, closing a challenge backed by top officials.

People seek ways to pause a difficult psychedelic experience. Psychedelic Science Review spotlights ketanserin’s promise. Here’s what’s known, what isn’t, and harm-reduction context for DMV readers.

Two federal marijuana sentences were cut as Washington debates moving some cannabis to Schedule III. Here’s what’s known now—and what DMV residents should watch.

A science-forward explainer on cross-tolerance between LSD and DOI, how repeat dosing can blunt effects, and what careful timing means for patients and clinicians.

NORML reports, citing FBI data, that in six states marijuana accounts for the majority of drug-related arrests — highlighting stark differences in enforcement and compliance risks.